In the wake of the increase in Current Liabilities in the first quarter 2022, Quick Ratio fell to 5.03 below Checkmate Pharmaceuticals Inc average.

Within Biotechnology & Pharmaceuticals industry 111 other companies have achieved higher Quick Ratio than Checkmate Pharmaceuticals Inc in first quarter 2022. While Quick Ratio total ranking in the first quarter 2022 has deteriorated compared to the prior quarter from 1252 to 1420.

Explain Quick Ratio?
How much Cash & cash equivalents CMPI�s has?
What are CMPI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CMPI/financial-strength

https://api.csimarket.com/api/v1/companies/CMPI/fundamentals

https://api.csimarket.com/api/v1/companies/CMPI/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

CMPI Quick Ratio	(Mar 31 2022) Q1	(Dec 31 2021) Q4	(Sep 30 2021) Q3	(Jun 30 2021) Q2	(Mar 31 2021) Q1
Y / Y Current Liabilities Change	63.34 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-30.03 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	5.03	Subscribe	Subscribe	Subscribe	Subscribe
CMPI's Total Ranking	# 1420	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	27.33 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-15.28 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio first quarter 2022 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 112
Healthcare Sector	# 556
Overall Market	# 1390

Quick Ratio Statistics
High	Average	Low
29.4	11.62	0.79
(Dec 31 2020)		(Dec 31 2019)

Financial Statements
Checkmate Pharmaceuticals Inc 's Current Liabilities	$ 12 Millions	Visit CMPI's Balance sheet
Checkmate Pharmaceuticals Inc 's Cash & cash equivalent	$ 60 Millions	Visit CMPI's Balance sheet
Source of CMPI's Sales		Visit CMPI's Sales by Geography

Cumulative Checkmate Pharmaceuticals Inc 's Quick Ratio

CMPI's Quick Ratio for the trailling 12 Months

CMPI Quick Ratio	(Mar 31 2022) 12 Months	(Dec 31 2021) 12 Months	(Sep 30 2021) 12 Months	(Jun 30 2021) 12 Months	(Mar 31 2021) 12 Months
Y / Y Current Liabilities TTM Growth	15.48 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-44.46 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	8.29	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 5239	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	14.84 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-7.98 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to CMPI Financial Strength Comparisons >> Go to Compare CMPI Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q1 2022 to $11.94 millions, cumulative Quick Ratio decreased to 8.29 below the Checkmate Pharmaceuticals Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 189 other companies have achieved higher Quick Ratio than Checkmate Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2021 from 411 to 5239.

Explain Quick Ratio?
How much Cash & cash equivalents CMPI�s has?
What are CMPI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 190
Healthcare Sector	# 1177
Within the Market	# 5239

trailing twelve months Quick Ratio Statistics
High	Average	Low
13.12	10.95	8.29
(Jun 30 2021)		(Mar 31 2022)

Companies with similar Quick Ratio in the quarter ending Mar 31 2022, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Mar 31 2022 MRQ Cash & cash equivalent	Mar 31 2022 MRQ Current Liabilities
Curis Inc	13.61	$ 120.653 Millions	$ 8.867 Millions
Editas Medicine Inc	13.38	$ 488.362 Millions	$ 36.503 Millions
Caribou Biosciences Inc	12.73	$ 353.731 Millions	$ 27.788 Millions
Elevation Oncology inc	12.66	$ 132.062 Millions	$ 10.435 Millions
Achilles Therapeutics Plc	12.56	$ 173.338 Millions	$ 13.805 Millions
Allogene Therapeutics Inc	12.18	$ 449.050 Millions	$ 36.877 Millions
Jasper Therapeutics Inc	11.79	$ 70.400 Millions	$ 5.969 Millions
Adverum Biotechnologies Inc	11.66	$ 271.055 Millions	$ 23.237 Millions
Surrozen Inc	11.40	$ 92.514 Millions	$ 8.115 Millions
Voyager Therapeutics Inc	11.36	$ 166.833 Millions	$ 14.683 Millions
Immunovant Inc	11.09	$ 493.817 Millions	$ 44.520 Millions
Tenaya Therapeutics Inc	11.02	$ 210.454 Millions	$ 19.095 Millions
Tracon Pharmaceuticals Inc	10.99	$ 16.640 Millions	$ 1.514 Millions
Autolus Therapeutics Plc	10.89	$ 268.558 Millions	$ 24.666 Millions
Kalaris Therapeutics Inc	10.80	$ 201.375 Millions	$ 18.639 Millions
Tradeup Acquisition Corp	10.65	$ 0.322 Millions	$ 0.030 Millions
Armata Pharmaceuticals Inc	9.86	$ 46.408 Millions	$ 4.706 Millions
Passage Bio Inc	9.72	$ 267.090 Millions	$ 27.481 Millions
Senti Biosciences Holdings Inc	9.49	$ 38.140 Millions	$ 4.018 Millions
Tectonic Therapeutic Inc	9.44	$ 161.663 Millions	$ 17.130 Millions
Ginkgo Bioworks Holdings Inc	9.38	$ 1,492.971 Millions	$ 159.247 Millions
Jounce Therapeutics inc	9.31	$ 155.418 Millions	$ 16.702 Millions
Black Diamond Therapeutics Inc	9.23	$ 179.739 Millions	$ 19.469 Millions
Revolution Medicines Inc	9.03	$ 518.754 Millions	$ 57.458 Millions
Vectivbio Holding Ag	8.95	$ 221.416 Millions	$ 24.741 Millions
Kodiak Sciences Inc	8.80	$ 671.727 Millions	$ 76.334 Millions
Fennec Pharmaceuticals Inc	8.61	$ 18.390 Millions	$ 2.136 Millions
Dyadic International Inc	8.45	$ 15,440.093 Millions	$ 1,826.480 Millions
Tscan Therapeutics Inc	8.40	$ 140.838 Millions	$ 16.767 Millions
Imagenebio Inc	8.38	$ 212.375 Millions	$ 25.331 Millions

Date modified: 2026-10-07T00:41:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.